FMC Corporation
FMC · NYSE · Materials · United States
Financials at a glance
Source: SEC XBRLAnnual
Quarterly · last 8
Revenue (FY2025)
$3.5B
Net margin
-64.6%
ROE
-108.1%
Revenue CAGR (2y)
-12.1%
EPS (FY2025)
-17.88
Net profit (FY2025)
$-2.2B
Ask MarketChacha about FMC
Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.
Why it moved
- Sep 2, 2026
No specific catalyst identified in Sept 2 coverage; the sharp gain occurred amid ongoing market focus on Q2 results, guidance reset, and the Corteva herbicide partnership, with elevated short interest possibly contributing to volatility.
· confidence: low - Sep 1, 2026
FMC shares rose 3% with no identifiable company-specific catalyst on Sept 1; recent coverage continued to highlight the June herbicide partnership with Corteva and July Q2 results/guidance as shaping the longer-term outlook.
- Jul 24, 2026
No specific company catalyst or filing explains the decline; recent coverage noted steady trading amid positive crop protection demand and earnings outlook commentary, suggesting the move occurred with broader market or sector flows after recent gains.
· confidence: low - Jul 22, 2026
FMC rose with positive sector sentiment around crop protection demand supporting its earnings outlook and margins, ahead of its July 29 Q2 earnings release; no single new company-specific catalyst was identified for the session.
Daily moves with the verified reason behind them. Education only — not investment advice.
Financials
Yearly
| Period | Revenue | Net profit | EPS | Net margin | ROE |
|---|---|---|---|---|---|
| FY2025 | $3.5B | $-2.2B | -17.88 | -64.6% | -108.1% |
| FY2024 | $4.2B | $341.1M | 2.72 | 8.0% | 7.6% |
| FY2023 | $4.5B | $1.3B | 10.53 | 29.5% | 30.0% |
Quarterly
| Period | Revenue | Net profit | EPS | Net margin |
|---|---|---|---|---|
| 2026Q2 | $867.1M | $-186.6M | -1.49 | -21.5% |
| 2026Q1 | $758.6M | $-281.3M | -2.25 | -37.1% |
| 2025Q4 | $1.1B | $-1.7B | -13.74 | -158.8% |
| 2025Q3 | $542.2M | $-569.3M | -4.52 | -105.0% |
| 2025Q2 | $1.1B | $66.7M | 0.53 | 6.3% |
| 2025Q1 | $791.4M | $-15.5M | -0.12 | -2.0% |
| 2024Q4 | $1.2B | $-16.3M | -0.13 | -1.3% |
| 2024Q3 | $1.1B | $65.0M | 0.52 | 6.1% |
| 2024Q2 | $1.0B | $295.1M | 2.35 | 28.4% |
| 2024Q1 | $918.0M | $-2.7M | -0.02 | -0.3% |
| 2023Q4 | $1.1B | $1.1B* | 8.77 | — |
| 2023Q3 | $981.9M | $-3.5M | -0.03 | -0.4% |
| 2023Q2 | $1.0B | $30.5M | 0.24 | 3.0% |
* Net profit includes one-off / non-operating items (e.g. a settlement or accounting gain), so it doesn’t reflect operating performance — net margin is hidden for that period.
Figures as reported, in reporting currency. Source: SEC XBRL.
Filings & announcements
2026
- SEC7/30/2026
- SEC7/29/2026material
- SEC6/23/2026material
- SEC6/23/2026material
- SEC6/5/2026material
- SEC5/21/2026material
- SEC5/19/2026material
- SEC4/30/2026
- SEC4/29/2026material
- SEC4/20/2026material
- SEC2/27/2026
- SEC2/4/2026material
2025
- SEC12/12/2025material
- SEC12/9/2025material
- SEC12/3/2025material
- SEC10/30/2025
- SEC10/29/2025material
- SEC10/29/2025material
- SEC7/31/2025
- SEC7/30/2025material
In the news
- FMC stock holds in the low double digits as Q2 2026 results and herbicide partnership shape expectatAD HOC NEWS · 9/1/2026
- FMC Corp. stock trades around $11 as Q2 2026 results and new herbicide partnership shape the outlookAD HOC NEWS · 9/1/2026
- FMC Corp. stock holds at $11.33 as Q2 2026 results and outlook frame the risk-rewardAD HOC NEWS · 8/31/2026
- FMC Corp. stock steadies around $11 as guidance reset puts earnings path under scrutinyAD HOC NEWS · 8/29/2026
- Fresenius stock steady as company trims FMC stake and eyes further growthAD HOC NEWS · 8/29/2026
- FMC Corp. stock holds value focus amid sparse dataAd-hoc-news.de · 8/27/2026
- FMC Corp. stock holds in a tight range as Q2 2026 loss reshapes guidanceAd-hoc-news.de · 8/26/2026
- FMC Corporation Stock Short Interest Rises to 31.36%Quiver Quantitative · 8/26/2026
Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.